| Monday 23 -
Tuesday 24 |
Tuesday, April 24 |
Chronic
renal disease |
Chair
:
François Vrtovsnik |
| 9:00 |
10.
Hyperuricemia : marker or risk factor |
Bruno
Moulin
(Strasbourg) |
| 9:30 |
11.
Metabolic acidosis : a progression factor ? |
Yaqoob
Muhammad
(Londres) |
| 10:00 |
12.
Vitamine D : goals and targets |
Jean-Claude
Souberbielle
(Paris) |
| 10:30 |
Coffee break |
|
Transplantation |
Chair
:
François Vrtovsnik |
| 11:00 |
13.
B lymphocytes in renal transplantation |
Renaud
Snadoudj
(Paris)
|
| 11:30 |
14.
CD28 inhibition : recent progress |
Bernard
Vanhove
(Paris) |
| 12:00 |
15.
Urine metabolomics and renal allograft histology |
David
Rush
(Manitoba) |
| 12:30 |
Lunch |
|
Physiopathology
: new signalling pathways : |
Chair
:
Fabiola Terzi |
| 2:00 |
16.
The EGF Receptor promotes glomerular injury in NCGN |
Guillaume
Bollée
(Montréal)
|
| 2:30 |
17.
Podocytes : M-TOR signalisation pathway |
Guillaume
Canaud
(Paris) |
| 3:00 |
18.
Endoplasmic reticulum stress |
Éric
Chevet
(Bordeaux) |
| 3:30 |
Coffee break |
|
|
Diabetes
|
Chair
:
Christian Boitard |
| 4:00 |
19. Metabolic Syndrome:
An emerging threat to renal function
|
Eberhardt
Ritz
(Heidelberg) |
| 4:30 |
20. Post-transplantation
diabetes |
Christophe
Legendre
(Paris) |
| 5:00 |
21. Treatment of diabetes
in CKD patients
|
Dominique
Joly
(Paris) |
| 5:30 |
End of sessions |
|
